D-dimer Testing Market Key Trends, Size, Growth, Shares And Forecast Research Report 2014 – 2022

At present, the in vitro diagnostics market is one of the fastest growing markets globally. This remarkable growth can be attributed to the improved health care awareness, preference of the people for preventive health checkups, accessibility to disease specific tests, and shift from manual to semi-automated and automated instruments. Diagnostic laboratories are facing challenges in delivering high-quality, efficient and timely testing solutions due to rising health care awareness and stringent regulations that put pressure on the health care budgets. This has led to growing adoption of automated solutions and new analyzers that deliver high throughput in lesser time and with enhanced efficiency. Point-of care testing has gained momentum in the past few years to meet the demand for quick turnaround time, thus accelerating reliable results. D-dimer assays and POC kits have been developed to confirm the exclusion of deep vein thrombosis (DVT), pulmonary embolism (PE), and disseminated intravascular coagulation (DIC).

Read Complete Report @ http://www.mrrse.com/d-dimer-market

The D-dimer testing market has been extensively analyzed on the basis of testing methods, applications, and geography. Testing methods include point-of-care testing (POC) and laboratory testing. Laboratory testing has been further segmented into coagulation analyzers and clinical chemistry analyzers. Applications comprise deep vein thrombosis (DVT), pulmonary embolism (PE), and disseminated intravascular coagulation (DIC). Each of the segments has been analyzed in detail for market trends, number of D-dimer tests, recent developments, outlook, and opportunities. The report provides current and future market size for each segment and sub-segment for the period from 2014 to 2022, in terms of revenue in USD million and number of tests in million, considering 2012 and 2013 as the base years. The compound annual growth rate (%CAGR) for each market segment has been provided for the forecast period from 2014 to 2022 along with the estimations of market size.

Inquiry for Check discount @ http://www.mrrse.com/enquiry/1493

Geographically, the global D-dimer testing market has been classified into six major geographical regions: North America (U.S., Canada), Europe (Germany, U.K.), Asia-Pacific (Japan, China), Latin America (Brazil, Mexico), MENA (Saudi Arabia, U.A.E.), and Rest of the World (RoW). The regions have been further segmented by major countries. The current and future market sizes in terms of revenue (USD million) and number of tests (million) of these regional markets and their major countries have been provided in the report for the period from 2012 to 2022, with their growth rate (%) for the period from 2014 to 2022. The study also offers a list of recommendations and highlights of the market for new companies willing to enter the market and for existing companies to increase market shares, which is likely to help in the decision-making process. Heat map analysis has also been provided for various hematology and automated analyzer manufacturers designed to perform D-dimer tests.

The market overview section of the report demonstrates the market dynamics and market trends such as drivers, restraints, and opportunities that influence the current and future status of the D-dimer industry. The report also covers market attractiveness analysis, Porter’s Five Forces analysis and key market share analysis in the market overview section, in order to give a thorough analysis of the overall competitive scenario in the global D-dimer testing market.

Get a Free Sample Copy of the Report @ http://www.mrrse.com/checkdiscount/1493

The report concludes with the company profiles section that includes key information about the major players in the market. Key players profiled in this report include Abbott Laboratories, Alere, Inc., Beckman Coulter, Inc., Bio/Data Corporation, Becton, Dickinson and Company, Corgenix, F. Hoffman-La Roche Ltd., Helena Biosciences, Siemens Healthcare, Sysmex Corporation, Thermo Fisher Scientific, and Trinity Biotech. Each of these players is profiled in the report considering parameters such as company overview, financial overview, business strategies, product portfolio, and recent developments.